BIOPHEN™ FVIII variant
(Emicizumab insensitive)
Determination of Factor VIII (FVIII) activity
- CE-IVD
-
R1, R2, R3: 2 x 2.5 mL
R4: 4 x 20 mL
-
227102
Method for the detection of FVIII deficiency states and monitoring of replacement therapy (except Emicizumab) on patients who are suspected of congenital or acquired deficiency and potency estimation of FVIII concentrates.
You must be signed-in as a distributor to download this document
